Cargando…
Management of rheumatoid arthritis in People’s Republic of China – focus on tocilizumab and patient considerations
The prevalence of rheumatoid arthritis (RA) is 0.19%–0.41% in Chinese population. RA exerts profound influence on health-related quality of life (HRQoL), which imposed huge burdens on patients physically, mentally, and economically. As a developing country, People’s Republic of China faces enormous...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435442/ https://www.ncbi.nlm.nih.gov/pubmed/25999757 http://dx.doi.org/10.2147/IJGM.S81633 |